PFSA
Profusa, Inc. Common Stock
NASDAQ: PFSA · HEALTHCARE · MEDICAL DEVICES
$0.60
+10.08% today
Updated 2026-04-30
Market cap
$2.26M
P/E ratio
—
P/S ratio
104.68x
EPS (TTM)
$-107.01
Dividend yield
—
52W range
$0 – $413
Volume
6.2M
Profusa, Inc. Common Stock (PFSA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Gross margin | — | — | — | — | — |
| R&D | $7.66M | $4.20M | $2.04M | $1.61M | $2.80M |
| SG&A | $4.77M | $5.24M | $4.08M | $2.99M | $24.90M |
| Operating income | $-11.69M | $-11.14M | $-6.07M | $-4.50M | $-13.22M |
| Operating margin | — | — | — | — | — |
| EBITDA | $-5.05M | $-13.22M | $-6.00M | $-4.81M | $-13.22M |
| EBITDA margin | — | — | — | — | — |
| EBIT | $-6.23M | $-13.95M | — | — | — |
| Interest expense | $4.08M | $6.27M | $4.28M | $4.42M | $5.09M |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-10.31M | $-20.22M | $-10.28M | $-9.23M | $-35.82M |
| Net income growth (YoY) | — | -96.1% | +49.1% | +10.2% | -288.1% |
| Profit margin | — | — | — | — | — |